Anatomy of a Drug Manufacturing Plant (Part 1 in a Three-Part Series Examining the Financial Impact of New Plant Construction)

Anatomy of a Drug Manufacturing Plant (Part 1 in a Three-Part Series Examining the Financial Impact of New Plant Construction)

Anatomy of a Drug Manufacturing Plant (Part 1 in a Three-Part Series Examining the Financial Impact of New Plant Construction)

SUGAR LAND--July 26, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Drugs are essential in today's world. In addition to curing and treating a stunning array of medical conditions, the process to develop and manufacture those products can be a real panacea to financial woes. Cities across the nation vie for pharmaceutical and biotech companies' consideration as the site for their next new plant or research campus. While economic developers recognize the value in landing one of these projects, there is often a lack of appreciation from the general population as to why these plants are sought so aggressively and often offered huge financial incentives.

Within this article: The intricacies of establishing a Pharma-Biotech plant, from the earliest days through site selection

Companies featured: Baxter International Corporation (NYSE:BAX), Shire plc (NASDAQ:SHPG)

Subscribe Now!(All Fields Required)

Standard Membership - Free